[Form 4] Vital Farms, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Wrede Thilo, identified as Chief Financial Officer of Vital Farms, Inc. (VITL), reported a sale of common stock on 08/11/2025. The filing shows 1,200 shares were disposed of at a reported price of $45.56 per share.

After the transaction the reporting person beneficially owned 54,987 shares. The filing states the sale was made pursuant to a Rule 10b5-1 trading plan adopted March 13, 2025. The Form 4 was submitted by one reporting person and lists a C/O Vital Farms Austin address.

Positive

• Sale executed pursuant to a Rule 10b5-1 trading plan adopted March 13, 2025, which documents pre-arranged trading intentions.
• Clear disclosure of post-transaction beneficial ownership: reporting person retains 54,987 shares after the sale.

Negative

• None.

Insights

Corporate Governance Expert

TL;DR: Routine, pre-arranged insider sale under a 10b5-1 plan — transparency is appropriate; not by itself material.

The Form 4 documents a scheduled disposition of 1,200 shares by the CFO under a Rule 10b5-1 plan adopted March 13, 2025. Use of a documented plan typically reduces concerns about opportunistic timing because trades follow pre-set parameters. The filing discloses the post-transaction beneficial ownership of 54,987 shares, which preserves transparency for investors assessing insider alignment.

Securities Analyst

TL;DR: Small, pre-planned sale with clear disclosure; unlikely to be material to VITL's capital structure.

The reported sale — 1,200 shares at $45.56 on 08/11/2025 — is executed under an explicit 10b5-1 plan, reducing information asymmetry. The Form 4 indicates continued meaningful ownership by the reporting person (54,987 shares after the transaction). There is no other compensatory or derivative activity disclosed in this filing to suggest a broader change in insider exposure.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wrede Thilo

(Last) (First) (Middle)

C/O VITAL FARMS, INC.

3601 SOUTH CONGRESS AVENUE, SUITE C100

(Street)

AUSTIN TX 78704

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Vital Farms, Inc. [ VITL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CHIEF FINANCIAL OFFICER

3. Date of Earliest Transaction (Month/Day/Year)
08/11/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/11/2025		S(1)		1,200	D	$45.56	54,987	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These sales were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2025.

	/s/ Francis Cullo, Attorney-in-Fact	08/13/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

Who filed the Form 4 for Vital Farms (VITL)?

Wrede Thilo, identified as Chief Financial Officer, is the reporting person listed on the Form 4.

What transaction was reported for VITL on 08/11/2025?

A reported sale of 1,200 shares of Vital Farms common stock on 08/11/2025 at a price of $45.56 per share.

Was the sale by the Vital Farms insider part of a trading plan?

Yes. The filing states the sales were made pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2025.

How many Vital Farms shares did the reporting person own after the transaction?

The Form 4 reports 54,987 shares beneficially owned following the reported transaction.

Did the Form 4 disclose any derivative transactions or option activity for VITL?

No. Table II for derivative securities contains no entries in this filing.